Qiagen Q3 non-GAAP earnings up 61% on strong COVID-19 testing demand

• QIAGEN N.V. (QGEN +1.4%) Q3 results:
• Sales up 26% to $483.8M.
• Non-GAAP EPS up 61% to $0.58.
• Q4 guidance: Sales growth: 24 - 27% ($512.7M - 525.1M); non-GAAP EPS: $0.58 - 0.60. Consensus: $0.64/$523.3M.
• 2020 guidance: Sales growth: 20% ($1.84B); non-GAAP EPS: $2.07 - 2.09. Consensus: $2.09/$1.80B.
• CEO Thierry Bernard says, “Our results for the third quarter reflect a dynamic performance driven by an ongoing very high level of sales for product groups used in the COVID-19 pandemic response and by improving demand trends in other areas of the portfolio.”
• https://seekingalpha.com/news/3626598-qiagen-q3-non-gaap-earnings-up-61-on-strong-covidminus-19-testing-demand